Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia

por Jentzsch, Madlen, Schwind, Sebastian, Bach, Enrica, Stasik, Sebastian, Thiede, Christian, Platzbecker, Uwe
Publicado 2019

Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape

por Schwind, Sebastian, Jentzsch, Madlen, Kubasch, Anne Sophie, Metzeler, Klaus H., Platzbecker, Uwe
Publicado 2021

MicroRNA Expression Patterns Reveal a Role of the TGF-β Family Signaling in AML Chemo-Resistance

por Reichelt, Paula, Bernhart, Stephan, Wilke, Franziska, Schwind, Sebastian, Cross, Michael, Platzbecker, Uwe, Behre, Gerhard
Publicado 2023

Outcomes of Older Patients with NPM1 Mutated and FLT3-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation

por Jentzsch, Madlen, Grimm, Juliane, Bill, Marius, Goldmann, Karoline, Schulz, Julia, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian
Publicado 2020

Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation

por Brauer, Dominic, Backhaus, Donata, Pointner, Rosmarie, Vucinic, Vladan, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian, Jentzsch, Madlen
Publicado 2021

P508: THE PROGNOSTIC SIGNIFICANCE OF THE MEASURABLE RESIDUAL DISEASE STATUS WITHIN THE THREE AML ELN2022 RISK GROUPS

por Bischof, Lara, Ussmann, Jule, Brauer, Dominic, Backhaus, Donata, Franke, Georg-Nikolaus, Vucinic, Vladan, Platzbecker, Uwe, Schwind, Sebastian, Jentzsch, Madlen
Publicado 2023

Clinical Implications of the FLT3-ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation

por Jentzsch, Madlen, Bischof, Lara, Brauer, Dominic, Backhaus, Donata, Ussmann, Jule, Franke, Georg-Nikolaus, Vucinic, Vladan, Platzbecker, Uwe, Schwind, Sebastian
Publicado 2023

Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML

por Jentzsch, Madlen, Bill, Marius, Grimm, Juliane, Brauer, Dominic, Backhaus, Donata, Goldmann, Karoline, Schulz, Julia, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian
Publicado 2020

ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation

por Jentzsch, Madlen, Grimm, Juliane, Bill, Marius, Brauer, Dominic, Backhaus, Donata, Goldmann, Karoline, Schulz, Julia, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian
Publicado 2020

Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation

por Jentzsch, Madlen, Grimm, Juliane, Bill, Marius, Brauer, Dominic, Backhaus, Donata, Schulz, Julia, Goldmann, Karoline, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian
Publicado 2021

Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission

por Jentzsch, Madlen, Bischof, Lara, Backhaus, Donata, Brauer, Dominic, Schulz, Julia, Franke, Georg-Nikolaus, Vucinic, Vladan, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian
Publicado 2022

A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia...

por Backhaus, Donata, Brauer, Dominic, Pointner, Rosmarie, Bischof, Lara, Vucinic, Vladan, Franke, Georg-Nikolaus, Niederwieser, Dietger, Platzbecker, Uwe, Jentzsch, Madlen, Schwind, Sebastian
Publicado 2022

P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD) RELAPSE AFTER ACHIEVEMENT OF A FIRST MRD-NEGATIVE REMISSION

por Jentzsch, Madlen, Bischof, Lara, Ussmann, Jule, Brauer, Dominic, Backhaus, Donata, Pham Thanh, Tung, Franke, Georg-Nikolaus, Vucinic, Vladan, Platzbecker, Uwe, Schwind, Sebastian
Publicado 2023

PB2450: SEX-ASSOCIATED OUTCOME DIFFERENCES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

por Ussmann, Jule, Bischof, Lara, Backhaus, Donata, Brauer, Dominic, Pointner, Rosmarie, Franke, Georg-Nikolaus, Vucinic, Vladan, Merz, Maximilian, Platzbecker, Uwe, Schwind, Sebastian, Jentzsch, Madlen
Publicado 2023

Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

por Backhaus, Donata, Jentzsch, Madlen, Bischof, Lara, Brauer, Dominic, Wilhelm, Christina, Schulz, Julia, Franke, Georg-Nikolaus, Pönisch, Wolfram, Vucinic, Vladan, Platzbecker, Uwe, Schwind, Sebastian
Publicado 2021

P1315: THE CHRONOLOGICAL SEQUENCE OF 12 GY TOTAL BODY IRRADIATION AND CYCLOPHOSPHAMIDE CONDITIONING DOES NOT IMPACT OUTCOMES IN AML PATIENTS UNDERGOING MYELOABLATIVE ALLOGENEIC STE...

por Franke, Georg-Nikolaus, Ussmann, Jule, Backhaus, Donata, Henrik Nicolay, Nils, Vucinic, Vladan, Herling, Marco, Schetschorke, Birthe, Hell, Saskia, Platzbecker, Uwe, Schwind, Sebastian, Jentzsch, Madlen
Publicado 2023

Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome

por Franke, Georg-Nikolaus, Dumann, Konstantin, Jentzsch, Madlen, Monecke, Astrid, Doehring, Christine, Nehring-Vucinic, Claudia, Schwind, Sebastian, Niederwieser, Dietger, Platzbecker, Uwe, Ziemer, Mirjana, Vucinic, Vladan
Publicado 2021

Nanochannel Electroporation as a Platform for Living Cell Interrogation in Acute Myeloid Leukemia

por Zhao, Xi, Huang, Xiaomeng, Wang, Xinmei, Wu, Yun, Eisfeld, Ann‐Kathrin, Schwind, Sebastian, Gallego‐Perez, Daniel, Boukany, Pouyan E., Marcucci, Guido I., Lee, Ly James
Publicado 2015

Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation

por Jentzsch, Madlen, Grimm, Juliane, Bill, Marius, Küpper, Johannes, Backhaus, Donata, Brauer, Dominic, Schulz, Julia, Franke, Georg-Nikolaus, Vucinic, Vladan, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian
Publicado 2021

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation

por Jentzsch, Madlen, Bischof, Lara, Ussmann, Jule, Backhaus, Donata, Brauer, Dominic, Metzeler, Klaus H., Merz, Maximilian, Vucinic, Vladan, Franke, Georg-Nikolaus, Herling, Marco, Platzbecker, Uwe, Schwind, Sebastian
Publicado 2022